UMIN000049408Completed
Effects of combined SGLT2 inhibitor and DPP-4 inhibitor therapy on advanced glycation end products
Akishima ClinicUniversity Hospital Medical Information Networkdrug
VerifiedUniversity Hospital Medical Information Network
Study focus
- Disease/Condition
- Type 2 diabetes
- Study type
- Interventional
- Intervention type
- drug
Sponsor & location
- Primary sponsor
- Akishima Clinic
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 21, 2020
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000049408
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000049408 through Pure Global AI's free database. This phase not specified trial is sponsored by Akishima Clinic and is currently Completed. The study focuses on Type 2 diabetes.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.